Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation

Despite the advances in immunosuppressive medications, antibody-mediated rejection (AMR) continues to be a major cause of kidney allograft failure and remains a barrier to improving long-term allograft survival. Recently, there have been significant advances in the understanding of the pathophysiolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuazzam, Farah, Dubrawka, Casey, Abdulhadi, Tarek, Amurao, Gwendolyn, Alrata, Louai, Yaseen Alsabbagh, Dema, Alomar, Omar, Alhamad, Tarek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419906/
https://www.ncbi.nlm.nih.gov/pubmed/37568318
http://dx.doi.org/10.3390/jcm12154916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419906/
https://www.ncbi.nlm.nih.gov/pubmed/37568318
http://dx.doi.org/10.3390/jcm12154916

Ejemplares similares